These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 314807)

  • 1. The general pharmacology of a novel antitussive compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antitussive activity of a novel compound RU 20201.
    Pickering RW; James GW
    Arzneimittelforschung; 1979; 29(2):287-9. PubMed ID: 582141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on dl-glaucine phosphate as an antitussive.
    Kasé Y; Kawaguchi M; Takahama K; Miyata T; Hirotsu I; Hitoshi T; Okano Y
    Arzneimittelforschung; 1983; 33(7):936-46. PubMed ID: 6354197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of N-(2-picolyl)-N-phenyl-N-(2-piperidinoethyl)amine (TAT-3), a new antitussive agent.
    Kasé Y; Yuizono T; Tachibana K; Miyata T; Kito G; Miyano S
    Arzneimittelforschung; 1969 Dec; 19(12):1916-27. PubMed ID: 4392320
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative pharmacological study of antitussive preparations derived from piperazine].
    Le Douarec JC; Régnier G; Canévari R
    Arzneimittelforschung; 1965 Nov; 15(11):1330-7. PubMed ID: 5899868
    [No Abstract]   [Full Text] [Related]  

  • 6. Antitussive effect of RU-20201--central and peripheral actions.
    Yanaura S; Fujikura H; Hosokawa T; Kitagawa H; Kamei J; Misawa M
    Jpn J Pharmacol; 1984 Mar; 34(3):289-98. PubMed ID: 6727071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological studies of a new potent antitussive agent, 14-hydroxy-dihydro-6 beta-thebainol-4-methyl ether (oxymethebanol)].
    Takagi H; Kobayashi S; Kumakura S; Mori M; Koike H
    Nihon Yakurigaku Zasshi; 1969 Mar; 65(2):120-45. PubMed ID: 4390383
    [No Abstract]   [Full Text] [Related]  

  • 8. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). I. Action on respiratory function and acute toxicity.
    Rispat G; Burgi H; Cosnier D; Duchêne-Marullaz P; Streichenberger G
    Arzneimittelforschung; 1976 Apr; 26(4):523-30. PubMed ID: 8057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
    Cosnier D; Hache J; Labrid C; Rispat G
    Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological researches on 2-(7'-theophyllinemethyl)1,3-dioxolane.
    Franzone JS; Reboani C; Fonzo D; Di Carlo R
    Farmaco Sci; 1981 Mar; 36(3):201-19. PubMed ID: 6262105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some observations on the pharmacology of mitragynine.
    Macko E; Weisbach JA; Douglas B
    Arch Int Pharmacodyn Ther; 1972; 198(1):145-61. PubMed ID: 4626477
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacology of secoverine, a new spasmolytic agent with specific antimuscarinic properties. Part 2: General pharmacological properties.
    Zwagemakers JM; Claassen V
    Arzneimittelforschung; 1980; 30(9):1526-34. PubMed ID: 7193021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of ethyl dibunate, a new antitussive agent.
    Shemano I; Beiler JM; Hitchens JT
    Arch Int Pharmacodyn Ther; 1967 Feb; 165(2):410-24. PubMed ID: 6031473
    [No Abstract]   [Full Text] [Related]  

  • 14. [General pharmacological studies on tramadol, a potent analgetic agent (author's transl)].
    Osterloh G; Friderichs E; Felgenhauer F; Günzler WA; Henmi Z; Kitano T; Nakamura M; Hayashi H; Ishii I
    Arzneimittelforschung; 1978; 28(1a):135-51. PubMed ID: 305247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of xyloxemine hydrochloride, 2-[2-(di-2,6-xylylmethoxy) ethoxy]-N,N-dimethylethylamine hydrochloride (BS 6748), a new antitussive agent.
    Tersteege HM; Funcke AB; Louwerse WJ; Nauta WT
    Arch Int Pharmacodyn Ther; 1966 Jun; 161(2):314-33. PubMed ID: 5926874
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological properties of 2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2429. Part 2: General pharmacological investigation.
    Sofia RD; Diamantis W; Gordon R; Edelson J; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):782-9. PubMed ID: 405977
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacology of a new potent analgesic].
    Herrmann M; Steinbrecher W; Heldt W
    Arzneimittelforschung; 1970 Aug; 20(8):977-83. PubMed ID: 5536518
    [No Abstract]   [Full Text] [Related]  

  • 18. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide.
    Saito T; Ukai K; Masuda T; Nakagawa T; Kimura K; Fujii M; Wakatsuki K; Saeki M; Kasai H
    Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitussive activity and other related pharmacological properties of d-3-methyl-N-methylmorphinan (AT-17).
    Kasé Y; Kito G; Miyata T; Uno T; Takahama K; Ida H
    Arzneimittelforschung; 1976; 26(3):353-60. PubMed ID: 989326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antitussive actions of the drug Ru 20201 given as an aerosol to cats.
    Korpas J; Nosalova G; Widdicombe JG
    J Pharm Pharmacol; 1978 Sep; 30(9):563-5. PubMed ID: 29095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.